VXRT
Biotechnology · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when Vaxart, Inc. publishes a filing, an earnings call transcript or a press release.
Get VXRT alertsMichael Finney is recorded as CEO at Vaxart, Inc. (VXRT). The proxy statement of Vaxart, Inc. reports total compensation of $305,390 for Michael Finney in fiscal 2024, including a base salary of $110,521. Disclosed compensation is on record for 2 fiscal years. Michael Finney has spoken on 1 earnings call across 1 company, most recently for Vaxart, Inc. on March 14, 2024. Vaxart, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vaxart, Inc. includes Andrei Floroiu (CEO), Michael J. Finney (CEO and Board Member), Steven Lo (CEO and Board Member) and 7 others.
“It's a pleasure to be speaking with you at this exciting time in the company's development.”
Start not stated–2025-09-30
VXRT
Biotechnology · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Vaxart, Inc. (VXRT) | CEO | $110,521 | $305,390 |
| 2023 | Vaxart, Inc. (VXRT) | CEO | — | — |